Stocks Health care NEPH
NASDAQ · Health careNephros Inc (NEPH)
Nephros Inc brought in $20.7M of revenue over the twelve months to June 30, 2026, up 24.2% from a year earlier. Net income was $1.7M, a net margin of 8.4%. At June 30, 2026 it held $4.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
Key facts about Nephros Inc
- Net worth
- Nephros Inc has a market value (market cap) of $34.2M at the latest share price, and shareholders' equity of $12M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $18.8M (+32.7% year on year), with net income of $1.2M. Over the 12 months to June 30, 2026: revenue $20.7M, net income $1.7M.
- Cash flow
- In fiscal 2025 operations brought in $1.6M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 10, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Nephros Inc's next report is expected around May 6, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Nephros Inc does
Nephros Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NEPH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $18.8M | $1.2M | $0.11 | n/a |
| 2024 | $14.2M | $74K | $0.01 | -$547K |
| 2023 | $14.2M | -$1.6M | -$0.15 | $752K |
| 2022 | $10M | -$7.4M | -$0.73 | -$3.4M |
| 2021 | $10.2M | -$3.9M | -$0.41 | -$1.5M |
| 2020 | $8.6M | -$4.5M | -$0.52 | -$7.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where NEPH ranks in Health care
Latest SEC filings
What Nephros Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 16, 2026Activist stake changed SCHEDULE 13D/A
- September 16, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 36% to $6M versus the same quarter last year; diluted EPS $0.11 versus $0.02.
- August 6, 2026
- June 15, 2026
- May 7, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 6.9% to $5.2M versus the same quarter last year; diluted EPS $0.01 versus $0.05.
- April 30, 2026Annual report (amended) 10-K/A · period to December 31, 2025Revenue rose 33% to $18.8M versus the prior year; diluted EPS $0.11 versus $0.01.
- March 27, 2026
- March 12, 2026Annual report 10-K · period to December 31, 2025Revenue rose 33% to $18.8M versus the prior year; diluted EPS $0.11 versus $0.01.
Insider trades
What the people running Nephros Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 6 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 14, 2026 | Amron Arthur HDirector | Other change | 17,749 | - |
| September 14, 2026 | Amron Arthur HDirector | Other changeindirect | 2,836 | - |
| September 14, 2026 | Amron Arthur HDirector | Other changeindirect | 22,710 | $89.7K |
| September 14, 2026 | Wexford Capital LP10% owner | Other changeindirect | 3,355,111 | - |
| September 14, 2026 | Wexford Capital LP10% owner | Other changeindirect | 22,710 | $89.7K |
| August 18, 2026 | Wexford Capital LP10% owner | Exercised options | 812 | $2.9K |
| August 12, 2026 | Amron Arthur HDirector | Received as pay | 2,418 | - |
| May 11, 2026 | Amron Arthur HDirector | Received as pay | 3,574 | - |
Who owns NEPH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Charles E. Davidson13G, passive with 1 related filers | 5.68% | September 16, 2026 |
| Topline Capital Management, LLC13G, passive with 2 related filers | 5.6% | November 14, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 33 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Wexford Capital LP | 3,600,552 | 0 |
| Topline Capital Management, LLC | 535,698 | -46,269 |
| Vanguard Capital Management LLC | 198,643 | 0 |
| Morgan Stanley | 128,915 | +18,000 |
| Cornerstone Capital, Inc. | 128,700 | 0 |
| Bard Associates Inc | 118,003 | -3,199 |
| Renaissance Technologies LLC | 77,504 | -21,896 |
| Geode Capital Management, LLC | 70,263 | -2,662 |
| Mesirow Financial Investment Management, Inc. | 60,000 | -60,000 |
| HighTower Advisors, LLC | 59,710 | 0 |
| Navellier & Associates Inc | 53,479 | +34,353 |
| Essex Investment Management Co LLC | 38,927 | -57 |
| Vanguard Fiduciary Trust Co | 36,901 | 0 |
| Blair William & Co | 36,249 | 0 |
| Citadel Advisors LLC | 29,044 | +8,156 |
| Dimensional Fund Advisors LP | 22,164 | +1,419 |
| BlackRock, Inc. | 18,822 | new |
| De Lisle Partners LLP | 17,400 | -7,600 |
| Northern Trust Corp | 16,706 | +5,878 |
| State Street Corp | 15,698 | 0 |
Insiders
6 insiders reported holding 791,072 shares in total, about $2.5M at the last price.
| Holder | Shares |
|---|---|
| Wexford Capital LP10% owner | 223,539166,667 held indirectly |
| Banks Robert R. Jr.President and CEO | 190,000 |
| Amron Arthur HDirector | 184,16925,546 held indirectly |
| Spandow Oliver J.Director | 122,881 |
| Krandel JudyChief Financial Officer | 68,861 |
| Nettis Lisa MarieDirector | 1,622 |
Questions about NEPH
What does Nephros Inc do?
Nephros Inc is a company in the Health care sector, listed on NASDAQ as NEPH. Its shares trade on NASDAQ under the ticker NEPH.
What is Nephros Inc's net worth?
Nephros Inc has a market value (market cap) of $34.2M at the latest share price, and shareholders' equity of $12M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Nephros Inc profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $1.7M on revenue of $20.7M, a net margin of 8.4%.
How much revenue does Nephros Inc make?
Over the twelve months to June 30, 2026 Nephros Inc reported revenue of $20.7M. That is 24.2% more than a year earlier.
When did Nephros Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake changed from September 16, 2026.
When is Nephros Inc's next earnings report?
Nephros Inc's next report is expected around May 6, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare NEPH with
Follow NEPH
Get an email when Nephros Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Nephros Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.